Jeito Capital

Jeito Capital is an independent global investment firm that finances and accelerates clinical-stage biopharma companies developing therapies for serious diseases with significant unmet medical needs. Headquartered in Paris, France, the firm maintains a presence across Europe and the United States. Its stated remit spans the financing and growth of medical innovation rather than early discovery alone, with an emphasis on companies progressing therapies toward patients.

Alongside investment capital, Jeito provides multidisciplinary portfolio support to entrepreneurs and portfolio company leadership across the drug-development value chain. Coverage includes drug and clinical development, regulatory affairs, intellectual property, manufacturing, commercialisation and market access - disciplines intended to help portfolio companies build the capabilities required to become leaders in their therapeutic areas.

The firm describes its approach as entrepreneur-friendly and mission-driven, encapsulated in the phrase "go faster for the patient and further with the entrepreneur". Its stated objective combines the acceleration of promising therapies through development with support for patient access to innovation. Industry verticals span biopharma, pharmaceuticals and drug development, healthcare and medical innovation, and life sciences venture capital and growth investing.